🔎 Trials Near Me

Beranda › Penyakit Kardiovaskular › Michigan

Uji klinis Penyakit Kardiovaskular di Michigan

30 studi untuk Penyakit Kardiovaskular mencari peserta di lokasi di Michigan.

Kota di Michigan

Teks studi resmi (Bahasa Inggris)

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Revival Research Institute, LLC, Dearborn
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07783802

CARE-CP (Testing a Cardiovascular Ambulatory Rapid Evaluation for Patients With Chest Pain)

  • Henry Ford Hospital, Detroit
Menerima peserta
Usia 21 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT05897632

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Revival Research Institute, LLC - Dearborn, Dearborn
  • Aa Mrc Llc, Flint
  • Elite Research Center, LLC, Flint
  • dan 1 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07064473

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

  • UMH-Sparrow Clinical Research Institute, Lansing
  • MyMichigan Medical Center Midland, Midland
  • Healthy Heart Cardiology at Rochester Hills (Advanced Cardiology Associates, Rochester Hills
Menerima pesertaFase 4
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06909565

ADAPT Micro-Randomized Trial

  • University of Michigan, Ann Arbor
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06915220

A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

  • Profound Research LLC, Farmington Hills
Menerima pesertaFase 3
Usia 45 hingga 80 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07613294

Product Surveillance Registry

  • Ann Arbor
  • Bay City
  • Lansing
  • dan 2 lainnya
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT01524276

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  • Clinical Trial Site, Flint
  • Clinical Trial Site, Lansing
  • Clinical Trial Site, Midland
  • dan 5 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07181109

Zenith® Fenestrated+ Clinical Study

  • University of Michigan Health System, Ann Arbor
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT04875429

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

  • University of Michigan Health System, Ann Arbor
  • Henry Ford Saint John Hospital, Detroit
  • Corewell Health, Grand Rapids
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT03242642

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

  • University of Michigan, Ann Arbor
  • Henry Ford Health, Detriot
  • Corewell Health Grand Rapids Hospital, Grand Rapids
Menerima peserta
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06310031

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

  • Henry Ford Hospital, Detroit
  • AA Medical Research Center, Flint
  • Metro Health Univ of MI Health, Wyoming
Menerima pesertaFase 3
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07517263

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

  • Clinical Research Site, Ann Arbor
  • Clinical Research Site, Detroit
Menerima pesertaFase 2
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07333183

Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

  • VA Ann Arbor Healthcare System, Ann Arbor
  • University of Michigan, Ann Arbor
Menerima pesertaFase 4Sukarelawan sehat diterima
Usia 75 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT04262206

A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

  • C S Mott Children's Hospital, Ann Arbor
Menerima pesertaStudi observasional
Usia 7 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT05705531

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

  • Research Site, Dearborn Heights
  • Research Site, Detroit
  • Research Site, Farmington Hills
  • dan 4 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT07000357

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

  • Henry Ford Health System, Detroit
  • Healthy Heart Cardiology, Grand Rapids
  • MyMichigan Medical Center Midland - Clinical Research Department, Midland
  • dan 2 lainnya
Menerima pesertaFase 3
Usia 50 hingga 105 · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT07136012

Global Paradise System US Post Approval Study

  • Henry Ford Health, Detroit
  • Henry Ford St. John Hospital, Detroit
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT06297291

Hemodynamics After Resistance Training

  • University of Michigan School of Kinesiology, Ann Arbor
Menerima peserta
Usia 40 hingga 60 · Wanita · Diperbarui 3 Agu 2026 · NCT07022340

The TRICURE EFS Study

  • University of Michigan Hospital and Health Systems, Ann Arbor
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jul 2026 · NCT06506942

The RADIANCE CED Study

  • Henry Ford Hospital, Detroit
  • Henry Ford St. John Hospital, Detroit
Menerima pesertaStudi observasional
Usia 65 ke atas · Semua jenis kelamin · Diperbarui 16 Jul 2026 · NCT07231757

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

  • Ascension Providence Hospital Cardiology - Heart Cardiology, Howell
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT05934487

SPYRAL GEMINI Pilot Study

  • Henry Ford Providence Hospital, Southfield
Menerima peserta
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 24 Jun 2026 · NCT06907147

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

  • Henry Ford Hospital, Detroit
  • Spectrum Health Butterworth Hospital, Grand Rapids
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT06526195

Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell Transplantation

  • University of Michigan Rogel Cancer Center, Ann Arbor
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Mei 2026 · NCT05945121

Cardiovascular Health Improvement Project

  • University of Michigan, Ann Arbor
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Semua usia · Semua jenis kelamin · Diperbarui 29 Apr 2026 · NCT02306200

Designing and Assessing a Women Only Cardiac Rehabilitation (CARE) Program

  • University of Michigan, Ann Arbor
Menerima peserta
Usia 40 hingga 80 · Wanita · Diperbarui 4 Des 2025 · NCT06784895

Multi-Center Study of Clinical and Inflammatory Outcomes in Intensive Cardiac Rehabilitation and Traditional Cardiac Rehabilitation Programs

  • Trinity Health Ann Arbor, Ypsilanti
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Mei 2024 · NCT06424119

PARTNER 3 Trial - Aortic Valve-in-Valve

  • Henry Ford Hospital, Detroit
Menerima peserta
Semua usia · Semua jenis kelamin · Diperbarui 10 Mei 2024 · NCT03003299

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.